BioSpace News Archive

On track for anticipated June 1st approval of ibrexafungerp for the treatment of vaginal yeast infections and commercial launch in the second half of 2021

Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today announced that management will participate at the Investor Summit Conference on May 18, 2021.

CNS Pharmaceuticals, Inc., a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, reported its financial results for the quarter ended March 31, 2021.

Amneal Pharmaceuticals, Inc. announced that its management team will virtually attend the following investor conferences

Recro Pharma, Inc. (“Recro”; NASD:REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, today announced the closing of its previously announced underwritten public offering of 15,333,332 shares of its common stock

To meet the Biden Administration’s goal of having at least one COVID shot in the arms of 70 percent of Americans by July 4, vaccine hesitancy must be overcome, notes the Association of American Physicians and Surgeons.

Lennham Pharmaceuticals, a clinical-stage start-up focused on the creative use of deuterium chemistry to improve the metabolic and pharmacological profile of existing compounds, today announced that the United States Patent & Trademark Office (USPTO) issued U.S. Patent No. 11,000,534 with an expiration date of December 2040.

The American Cancer Society and the St. Baldrick’s Foundation awarded nearly $3 million to researchers fighting to end childhood cancer.

Genenta Science will present new clinical data from a Phase I/IIa study of Temferon in patients affected by glioblastoma multiforme in an oral presentation at the 2021 American Society for Gene and Cell Therapy Annual Meeting, taking place virtually on May 11-14, 2021.

The demand within the global non-invasive ventilators market is set to increase at a sound pace in the times to follow.